Ministry of AYUSH has granted Approval to Accuprec Research Labs Pvt. Ltd. for carrying out tests or analysis on Ayurvedic, Siddha and Unani drugs or raw materials used by the manufacturers thereof on behalf of licencees for Manufacture for sale drugs of Ayurvedic, Siddha or Unani drugs. The approval has been given for Chemistry, Pharmacognosy, Ayurveda, Siddha and Uniani as well as Microbiology categories of Ayurveda, Siddha and Uniani drugs. Accuprec is also involved in Toxicological and Clinical testing of Ayush formulations. Accuprec also provide innovative formulation and development solutions comprising modern approach for classifical Ayush formulations to make it acceptable globally. Shri Mulubhai Kandoriya, Managing Director of the Contract Research Organisation (CRO) has congratulated Directors - Dr. Rina Gokani, Dr. Manish Rachchh and Shri Mayur Kandoriya and entire staff including team leaders Sukrit Biswas, Mona Bhalani, Chandrajeet Singh and Bhushan Amrukar for getting the approval of Ministry of AYUSH. He expressed hope that now the CRO can also focus more in Research & Analysis of Ayurvedic, Siddha and Unani drugs or raw materials. We have also plan to develop more Ayurvedic formulations and getting patents.
With an increase in lifestyle-related disorders there is a worldwide resurgence of interest in holistic systems of health care, particularly with respect to the prevention and management of chronic, non-communicable and systemic diseases. It is increasingly understood that no single healthcare system can provide satisfactory answers to all the health needs of modern society. Evidently there is a need for a new inclusive and integrated health care regime that should guide health policies and programmes in future. India has an advantage in this global resurgence of interest in holistic therapies as it has a rich heritage of indigenous medical knowledge coupled with strong infrastructure and skilled manpower in modern medicine. Medical pluralism is here to stay and the AYUSH sector has a critical role to play in the new and emerging situation.
The Ministry of AYUSH promotes and propagates Indian systems of Medicine and Homoeopathy, and is committed to infuse the wisdom of traditional medicine with the methodologies of modern science, scientifically validating the systems and presenting them in the scientific idiom, relating their efficacy to modern life styles. The Department has, over the years, developed a broad institutional framework to carry out its activities. The National Medicinal Plants Board (NMPB) functions under the Department to coordinate activities relating to conservation, cultivation, marketing, export and policy making for the development of the medicinal plants sector.
For Standardisation and testing of Drugs, various agencies have been put in plan by the Government of India. Four different Pharmacopoeia Committees are working for preparing official formularies / pharmacopoeias to evolve uniform standards in preparation of drugs of Ayurveda, Siddha, Unani and Homeopathy and to prescribe working standards for single drugs as well as compound formulations. A Drug Control Cell is working in the Department to deal with the matters pertaining to licensing, regulation and control of drugs and the spurious manufacture of Ayurvedic, Siddha and Unani Drugs and other matters. Two apex Laboratories, namely, Pharmacopoeial Laboratory for Indian Medicine (PLIM) and Homoeopathic Pharmacopoeial Laboratory (HPL) are functioning as Standard Setting-Cum-Drugtesting Laboratories for Indian Medicines and Homoeopathy respectively. Indian Medicines Pharmaceutical Corporation Ltd. (IMPCL), a Public Sector Undertaking, manufactures classical Ayurveda and Unani drugs.